Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera

[1]  V. Velcheti,et al.  Squamous cell lung cancer: Current landscape and future therapeutic options. , 2022, Cancer cell.

[2]  D. Wishart,et al.  Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials , 2022, Pharmacological Reviews.

[3]  Hantao Yao,et al.  Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis , 2022, Science Translational Medicine.

[4]  Zeping Hu,et al.  Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma , 2021, Nature Communications.

[5]  S. Heiles.  Advanced tandem mass spectrometry in metabolomics and lipidomics—methods and applications , 2021, Analytical and Bioanalytical Chemistry.

[6]  P. Massion,et al.  Risk stratification of indeterminate pulmonary nodules , 2021, Current opinion in pulmonary medicine.

[7]  Yunwen Tao,et al.  Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma , 2020, Nature Communications.

[8]  H. Sugimura,et al.  Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer , 2020, Clinical and Translational Oncology.

[9]  Li Zeyun,et al.  A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer , 2020, PloS one.

[10]  J. Buring,et al.  Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) , 2019, International journal of cancer.

[11]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[12]  M. Gaga,et al.  Lung nodules: A comprehensive review on current approach and management , 2019, Annals of thoracic medicine.

[13]  Xin Lu,et al.  Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry. , 2019, Journal of proteome research.

[14]  P. Massion,et al.  Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  G. Stieler,et al.  Evaluation of the solitary pulmonary nodule , 2019, Internal medicine journal.

[16]  U. Röhrig,et al.  Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond , 2019, Nature Reviews Drug Discovery.

[17]  Zhaoli Chen,et al.  Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling , 2018, Clinical Cancer Research.

[18]  R. Schneider,et al.  Metabolic intermediates – Cellular messengers talking to chromatin modifiers , 2018, Molecular metabolism.

[19]  J. Pouysségur,et al.  The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5) , 2018, The Journal of Biological Chemistry.

[20]  Lorenzo Bonomo,et al.  Lung nodules: size still matters , 2017, European Respiratory Review.

[21]  Paul M. Parizel,et al.  Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology , 2017, Insights into Imaging.

[22]  A. Bankier,et al.  Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. , 2017, Radiology.

[23]  R. Strausberg,et al.  Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells. , 2016, Cancer research.

[24]  J. Herman,et al.  Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum , 2016, Clinical Cancer Research.

[25]  Oliver Fiehn,et al.  Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer. , 2016, Cancer biomarkers : section A of Disease markers.

[26]  S. Stein,et al.  Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures. , 2016, Rapid communications in mass spectrometry : RCM.

[27]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[28]  A. Rossi,et al.  Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans , 2016, Journal of amino acids.

[29]  R. McCormack,et al.  EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). , 2015, American journal of cancer research.

[30]  P. Hammerman,et al.  Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics , 2015, Clinical Cancer Research.

[31]  Oliver Fiehn,et al.  Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry , 2015, Metabolites.

[32]  Harry J de Koning,et al.  Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. , 2014, The Lancet. Oncology.

[33]  Ronald C. Walker,et al.  Indeterminate Pulmonary Nodules: Risk for Having or for Developing Lung Cancer? , 2014, Cancer Prevention Research.

[34]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[35]  Lisa M. Schwartz,et al.  Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. , 2014, JAMA internal medicine.

[36]  A. Onn,et al.  Screening for lung cancer: time for large-scale screening by chest computed tomography , 2014, European Respiratory Journal.

[37]  L. Cantley,et al.  Targeting Metabolic Scavenging in Pancreatic Cancer , 2013, Clinical Cancer Research.

[38]  Christoph Steinbeck,et al.  The role of reporting standards for metabolite annotation and identification in metabolomic studies , 2013, GigaScience.

[39]  S. Lam,et al.  Probability of cancer in pulmonary nodules detected on first screening CT. , 2013, The New England journal of medicine.

[40]  Rafael Rosell,et al.  Genetics and biomarkers in personalisation of lung cancer treatment , 2013, The Lancet.

[41]  M. Mascalchi,et al.  Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[42]  A. Mitra,et al.  Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. , 2013, International journal of pharmaceutics.

[43]  Ali O. Farooqi,et al.  Lung cancers diagnosed at annual CT screening: volume doubling times. , 2012, Radiology.

[44]  A. Dirksen,et al.  CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.

[45]  P. Prorok,et al.  Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST) , 2011, Journal of medical screening.

[46]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[47]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[48]  J. Fechner,et al.  An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells , 2010, The Journal of Immunology.

[49]  O. Muzik,et al.  Quantification of Tryptophan Transport and Metabolism in Lung Tumors Using PET , 2009, Journal of Nuclear Medicine.

[50]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[51]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[52]  U. Grohmann,et al.  Tryptophan catabolism generates autoimmune-preventive regulatory T cells. , 2006, Transplant immunology.

[53]  U. Grohmann,et al.  The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells1 , 2006, The Journal of Immunology.

[54]  R. Dziadziuszko,et al.  Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study. , 2017, Acta biochimica Polonica.

[55]  Zhongyuan Xiang,et al.  Clinical significance of simultaneous determination of serum tryptophan and tyrosine in patients with lung cancer , 2011, Journal of clinical laboratory analysis.